Outcomes and Risk Factors of Different Treatment Strategies for Neuro-co-cardiological Diseases and Post-cardiac Surgery Cerebrovascular Diseases
NCT ID: NCT07012668
Last Updated: 2025-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2024-09-19
2027-09-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgical Techniques to Prevent Perioperative Neurologic Complications in Patients Undergoing Coronary Artery Bypass Grafting
NCT07302659
Stroke Study: Operative Strategies to Reduce Cerebral Embolic Events During Coronary Artery Bypass Surgery
NCT01502683
Multidisciplinary CAE and CABG Surgery to Optimize the Management of High-risk Patients During the Perioperative Period
NCT04960488
SAfety and EFficacy of Bridging Antithrombotic Therapy During Elective Non-cardiac Surgery
NCT04675801
Stroke and Carotid-Cerebral Vascular Disease After CABG
NCT05036044
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neuro-co-cardiological diseases: Simultaneous treatment
Simultaneous interventional therapy/Simultaneous surgical treatment/ Simultaneous hybrid surgical treatment
Interventional or surgical treatment
Simultaneous interventional or surgical treatment/staged interventional or surgical treatment
Neuro-co-cardiological diseases: Staged treatment
Staged interventional therapy/Staged surgical treatment/Staged hybrid surgical treatment
Interventional or surgical treatment
Simultaneous interventional or surgical treatment/staged interventional or surgical treatment
Neuro-co-cardiological diseases: Conservative treatment
Surgery/intervention for one disease and conservative treatment for another disease or Simultaneously conservative treatment
No interventions assigned to this group
Post-cardiac surgery Cerebrovascular disease: Surgery/Interventional Treatment
Post-cardiac surgery Cerebrovascular disease: Surgery/Interventional Treatment
Interventional or surgical treatment
Interventional or surgical treatment
Post-cardiac surgery Cerebrovascular disease: Conservative treatment
Post-cardiac surgery Cerebrovascular disease: Conservative treatment
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interventional or surgical treatment
Simultaneous interventional or surgical treatment/staged interventional or surgical treatment
Interventional or surgical treatment
Interventional or surgical treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with neuro-co-cardiological diseases or post-cardiac surgery cerebrovascular diseases.
Exclusion Criteria
2. Simultaneously merge other serious diseases;
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Anzhen Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiaochuan Huo
Prof
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Anzhen Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANGEL-NEUROCARD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.